openPR Logo
Press release

Melanoma Cancer Market Growth, Size, Share, Industry Report and Forecast 2021-2026

05-19-2021 10:52 AM CET | Health & Medicine

Press release from: Orion Market Research

Melanoma Cancer Market Growth, Size, Share, Industry Report

The global melanoma cancer market is anticipated to grow at a CAGR of around 12.3% during the forecast period (2021-2027). The factor propelling the growth of the market include the rise in the number of FDA approvals for melanoma cancer drugs/systems produced by key market players. For instance, in July 2021, Genentech, a subsidiary of F. Hoffmann-La Roche Ltd, got the approval for Tecentriq (atezolizumab) plus Cotellic (cobimetinib) and Zelboraf (vemurafenib). These drugs are used for the treatment of BRAF V600 mutation-positive advanced melanoma. The FDA approval is supported by results from the Phase 3 IMspire150 clinical trial done on peoples who suffered from advanced melanoma and previously untreated BRAF V600 mutation. The approval will support Roche to build a strong market for the Tecentriq/Cotellic combo.

To Request a Sample of our Report on Melanoma Cancer Market: https://www.omrglobal.com/request-sample/melanoma-cancer-market

Moreover, in May 2020, SciBase, announced that it has received approval from the FDA for Nevisense 3.0, the third generation of their Nevisense system for early melanoma detection. Nevisence is an AI-based point-of-care system that is used for the non-invasive evaluation of irregular moles. Through this approval for the system to detect early melanoma cancer will support the company to expand its marketing and sales activities in the market. Thus, these approvals by FDA will impact positively the growth of the melanoma cancer market during the forecast period.

(Get 15% Discount on Buying this Report)
A full Report of Melanoma Cancer Market is Available at: https://www.omrglobal.com/industry-reports/melanoma-cancer-market

Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027

Segment Covered-

• By Diagnosis
• By Therapy

Regions Covered-
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Competitive Landscape- Bristol-Myers Squibb Co., GlaxoSmithKline plc, AstraZeneca PLC, Amgen Inc, Novartis AG, Abbott Laboratories, Johnson & Johnson Services, Inc., and others.

Global Melanoma Cancer Market Segmentation

By Diagnosis
• Biopsy
• Computed Tomography (CAT) Scan
• Magnetic Resonance Imaging (MRI)
• Positron Emission Tomography (PET) Scan

By Therapy
• Chemotherapy
• Immunotherapy
• Targeted Therapy
• Radiation Therapy

Regional Analysis

North America
• United States
• Canada
Europe
• UK
• Germany
• Spain
• France
• Italy
• Rest of Europe

Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of The World
• Latin America
• Middle East & Africa

Company Profiles
• Abbott Laboratories
• Ab Sciences
• AbbVie Inc.
• Amgen, Inc.
• AstraZeneca plc
• Bristol-Myers Squibb Co.
• Castle Biosciences, Inc.
• Celgene Corp.
• Chinook Therapeutics, Inc.
• Daiichi Sankyo Co., Ltd.
• ENB Therapeutics
• Eisai Co Ltd.
• F. Hoffman-La Roche Ltd.
• GlaxoSmithKline PLC
• Incyte Corp.
• Iovance Biotherapeutics Inc.
• Johnson & Johnson Services, Inc.
• Merck & Co., Inc.
• Novartis AG
• Pierre Fabre S. A.
• SciBase AB

Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/melanoma-cancer-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Melanoma Cancer Market Growth, Size, Share, Industry Report and Forecast 2021-2026 here

News-ID: 2286533 • Views:

More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033. Infrastructure as Code (IaC) Service Market Overview The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to Understanding the Process
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033. Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,
Property Management Service Market Rising Demand and Growth Forecast Through 2033
Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033. Property Management Service Market Overview The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSilicon Technologies Co., Ltd., ZTE Corporation,
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033. 5G Chipset Market Overview The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT

All 5 Releases


More Releases for Melanoma

Rising Incidence Of Melanoma Cases Boosts Metastatic Melanoma Therapeutics Marke …
The Metastatic Melanoma Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Metastatic Melanoma Therapeutics Market Size During the Forecast Period? The market size for therapeutics in metastatic melanoma has swiftly increased in the past few years. It is projected to augment
Rising Incidence Of Melanoma Cases Boosts Metastatic Melanoma Therapeutics Marke …
What combination of drivers is leading to accelerated growth in the metastatic melanoma therapeutics market? The growth of the metastatic melanoma therapeutics market is anticipated to be fueled by the increasing prevalence of melanoma cases. Melanoma, a type of skin cancer, originates in the cells, known as melanocytes, that determine the skin's pigment. Melanomas can develop on any part of the skin. Metastatic melanoma therapeutics comprise various treatments designed to interrupt
Key Influencer in the Melanoma Therapeutics Market 2025: Surge In Melanoma Incid …
How Are the key drivers contributing to the expansion of the melanoma therapeutics market? The rise in melanoma cases is predicted to fuel the expansion of the melanoma therapeutics market. Melanoma, a type of skin cancer, begins in the melanocytes. The therapies and medications used to treat melanoma patients and mitigate the effects of cancer are known as melanoma therapeutics. An increase in melanoma cases, therefore, leads to a surge in
Skin Cancer Market By Cancer Type (Melanoma, Non-melanoma)
Most skin cancers are locally destructive malignant growth of the skin. They come from the epidermis cells, the skin's superficial layer. The vast majority of these types of skin cancers seldom spread (metastasize) to other areas of the body and become life-threatening, unlike cutaneous malignant melanoma. Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00018117/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis: • Pfizer Inc. • Bristol-Myers Squibb Company • Abbott Laboratories • Amgen, Inc. • Merck & Co., Inc. • Novartis AG • F. Hoffmann-La Roche Ltd • Sanofi S.A. • Qiagen NV • Sun Pharmaceutical Industries Ltd
Melanoma Diagnostics Market - Shining Light on Melanoma: Transforming Lives with …
Newark, New Castle, USA - new report, titled Melanoma Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Melanoma Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Melanoma Diagnostics market. The report offers an overview of the market, which
Intraocular Melanoma Treatment Market Drivers
Neurological disorder diagnostics tools are medical devices, which are used in diagnosis of various neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Multiple Sclerosis. The devices which are majorly used in diagnosis are imaging tools such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and in-vitro diagnostics tools such as biomarker and biopsy. Increasing prevalence of neurological disorders in the recent past has increased demand for diagnostic